141 related articles for article (PubMed ID: 15118997)
1. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level.
Choi EY; Kwon HM; Yoon YW; Kim D; Kim HS
Yonsei Med J; 2004 Apr; 45(2):255-62. PubMed ID: 15118997
[TBL] [Abstract][Full Text] [Related]
2. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function.
Palazzuoli A; Maisel A; Caputo M; Fineschi M; Quatrini I; Calabrò A; Campagna MS; Franci B; Grothgar S; Pierli C; Nuti R
Regul Pept; 2011 Feb; 167(1):129-33. PubMed ID: 21237213
[TBL] [Abstract][Full Text] [Related]
4. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T
Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.
Goyal BM; Sharma SM; Walia M
Indian Heart J; 2014; 66(2):183-7. PubMed ID: 24814112
[TBL] [Abstract][Full Text] [Related]
6. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries.
Palazzuoli A; Gennari L; Calabria P; Quatrini I; Vecchiato L; De Paola V; Campagna MS; Palazzuoli V; Nuti R
Am J Cardiol; 2005 Dec; 96(12):1705-10. PubMed ID: 16360361
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number.
Palazzuoli A; Rizzello V; Calabrò A; Gallotta M; Martini G; Quatrini I; Campagna MS; Franci B; Nuti R
Clin Chim Acta; 2008 May; 391(1-2):74-9. PubMed ID: 18328262
[TBL] [Abstract][Full Text] [Related]
10. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Sadanandan S; Cannon CP; Chekuri K; Murphy SA; Dibattiste PM; Morrow DA; de Lemos JA; Braunwald E; Gibson CM
J Am Coll Cardiol; 2004 Aug; 44(3):564-8. PubMed ID: 15358021
[TBL] [Abstract][Full Text] [Related]
11. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
12. Association between elevated B-type Natriuretic Peptide levels with extent of coronary artery disease in patients with unstable angina and NSTEMI.
Romel SM; Faruque M; Bari MA; Bari MS; Aditya GP; Choudhury AK; Khalequzzaman M; Alam MM; Razzaque MA; Rahman MA; Kabir MS; Ahmed KU; Alam MA
Mymensingh Med J; 2014 Jul; 23(3):544-51. PubMed ID: 25178608
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans.
Pascual-Figal DA; Antolinos MJ; Bayes-Genis A; Casas T; Nicolas F; Valdés M
Heart; 2007 Sep; 93(9):1077-80. PubMed ID: 17395669
[TBL] [Abstract][Full Text] [Related]
14. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
15. D-dimer plasma levels in NSTE-ACS patient.
Charoensri N; Pornratanarangsi S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S39-45. PubMed ID: 21721427
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
Palazzuoli A; Ascione R; Gallotta M; Calabrò A; Gonnelli S; Quatrini I; Campagna MS; Franci B; Nuti R
Int J Cardiol; 2009 Nov; 137(3):295-8. PubMed ID: 18707771
[TBL] [Abstract][Full Text] [Related]
17. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
[TBL] [Abstract][Full Text] [Related]
20. Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes.
Atwater BD; Milford-Beland S; Newby LK; Hernandez AF; Peacock WF; Gibler WB; Christenson RH; Ohman EM; Peterson ED; Roe MT
Am J Cardiol; 2007 Dec; 100(12):1727-33. PubMed ID: 18082516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
